![]() |
Trials |
A Multicenter, Open Label, Phase 1 Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INC280 Tablet Formulation With Food in Patients With cMET Dysregulated Advanced Solid TumorsCancer type: Multiple diagnosis, Solide tumores Phase: I Principal Investigator: Yachnin Jeffrey Country: SE Keywords: Sweden, Stockholm, cMET Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02925104?lead=Novartis&id=CINC280A2108&rank=1 |